The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro

Molecular and Cellular Biology

Volumn 17, Issue 10, 1997, Pages 5923-5934

  Lu, Hua ^a,b   Fisher, Robert P ^c   Bailey, Paul ^a   Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL FUNCTION; DNA BINDING; DNA SEQUENCE; ENZYME ACTIVITY; EXCISION REPAIR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CHEMISTRY; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION;

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE; DNA; HYBRID PROTEIN; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; SERINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR II; TRANSCRIPTION FACTOR IIH;

CYCLIN-DEPENDENT KINASES; DNA; HELA CELLS; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; SERINE; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030610565     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.10.5923     Document Type: Article

References (81)

1. Aboussekhra, A., M. Biggerstaff, M. K. Shivji, J. A. Vilpo, V. Moncollin, V. N. Podust, M. Protic, U. Hubscher, J. M. Egly, and R. D. Wood. 1995. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 80:859-868.
2. Barlow, C., S. Hiotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J. N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171.
3. Baudier, J., C. Delphin, D. Grunwald, S. Khochbin, and J. J. Lawrence. 1992 Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. USA 89:11627-11631.
4. Bayle, J. H., B. Elenbaas, and A. J. Levine. 1995. The carboxy-terminal domain of the p53 protein regulates sequence specific DNA binding through its nonspecific nucleic acid binding activity. Proc. Natl. Acad. Sci. USA 92:5729-5733.
5. Bischoff, J. R., P. N. Friedman, D. R. Marshak, C. Prives, and D. Beach. 1990. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA 87:4766-4770.
6. Bogue, M. A., C. Zhu, E. Aguilar-Cordova, L. A. Donehower, and D. B. Roth. 1996. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in seid mouse thymocytes. Genes Dev. 10:553-565.
7. Buckbinder, L., R. Talbott, S. Valesco-Miguel, I. Takenaka, B. Faha, B. R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649.
8. Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
9. 1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16:2445-2452.
10. Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355.
11. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
12. Drapkin, R., J. T. Reardon, A. Ansari, J. G. Huang, L. Zawel, K. Olin, A. Sancar, and D. Reinberg. 1994. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368:769-772.
13. Drapkin, R., A. Sancar, and D. Reinberg. 1994. Where transcription meets repair. Cell 77:9-12.
14. Dulic, V., W. K. Kaufmann, S. J. Lees, T. D. Tisty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
15. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
16. Feaver W. J., J. Q. Svejstrup, L. Bardwell, A. J. Bardwell, S. Buratowski, K. D. Gulyas, T. F. Donahue, E. C. Friedberg, and R. D. Kornberg. 1993. Dual roles of a multiprotein complex from S. cerevisiae in transcription and DNA repair. Cell 75:1379-1387.
17. Fields, S., and S. K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049.
18. Fiscella, M., S. J. Ullrich, N. Zambrano, M. T. Shields, D. Lin, S. P. Lees-Miller, C. W. Anderson, W. E. Mercer, and E. Appella. 1993. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8:1519-1528.
19. Fisher, F., M. Gerard, C. Chalut, Y. Lutz, S. Humbert, M. Kanno, P. Chambon, and J. M. Egly. 1992. Cloning of the 62-kilodalton component of basic transcription factor BTF2. Science 257:1392-1395.
20. Fisher R. P., P. Jin, H. M. Chamberlin, and D. O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47-57.
21. Fisher, R. P., and D. O. Morgan. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713-724.
22. Flores, O., H. Lu, and D. Reinberg. 1992. Factors involved in specific transcription by mammalian RNA polymerase II: identification and characterization of factor IIH. J. Biol. Chem. 267:2786-2793.
23. Fresquet, D., J. C. Labbe, J. Derancourt, J. P. Capony, S. Galas, S. Girard, T. Lorca, J. Shuttleworth, M. Doree, and J. C. Cavadore. 1993. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 ana other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J. 12:3111-3121.
24. Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta Gene Struct. Expr. 1287:77-102.
25. Graeber, A. J., C. Osmanian, T. Jack, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Graccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91.
26. Guidos, C. J., C. J. Williams, I. Grandal, G. Knowles, M. T. F. Huang, and J. S. Danska. 1996. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10:2038-2054.
27. Gurley, K. E., and C. J. Kemp. 1996. p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. Carcinogenesis 17:2537-2542.
28. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigen. J. Virol. 39:861-869.
29. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Hupp, T., D. Meek, C. A. Midgley, and D. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
31. Hupp, T. R., and D. P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol. 4:865-875.
32. Hupp, T. R., A. Sparks, and D. P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83:237-245.
33. Jamal, S., and E. B. Ziff. 1995. Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo. Oncogene 10: 2095-2101.
34. Jayaraman, L., and C. Prives. 1995. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81:1021-1029.
35. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
36. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
37. Ko, J. L., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
38. Labbe, J. C., A. M. Martinez, D. Fesquet, J. P. Capony, J. M. Darbon, J. Derancourt, A. Devault, N. Morin, J. C. Cavadore, and M. Doree. 1994. p40MO15 associates with a p36 subunit and requires both nuclear translocation and Thr176 phosphorylation to generate cdk-activating kinase activity in Xenopus oocytes. EMBO J. 13:5155-5164.
39. Lee, S., B. Elenbaas, A. J. Levine, and J. Griffith. 1995. p53 and its 14kDa C-terminal domain recognize primary DNA damage in the form of insertion/ deletion mismatches. Cell 81:1013-1020.
40. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
41. Levine, A. J., A. Chang, D. Dittmer, D. A. Notterman, A. Silver, K. Thorn, D. Welsh, and M. Wu. 1994. The p53 tumor suppressor gene. J. Lab. Clin. Med. 124:817-823.
42. Lin, J., J. Chen, B. Elenbass, and A. J. Levine. 1994. Several hydrophobic amino acids in the p53 N-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55kd protein. Genes Dev. 8:1235-1246.
43. Linke, S. P., K. C. Clarkin, A. DiLeonardo, A. Tsou, and G. M. Wahl. 1996. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:934-947.
44. Ljungman, M., and F. Zhang. 1996. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene 13:823-831.
45. Lu, H., O. Flores, R. Weinmann, and D. Reinberg. 1991. The nonphosphorylated form of RNA polymerase II preferentially associates with the preinitiation complex. Proc. Natl. Acad. Sci. USA 88:10004-10008.
46. Lu, H., and A. J. Levine. 1995. Human TAF-31 is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92:5154-5158.
47. Lu, H., and A. J. Levine. Unpublished data.
48. Lu, H., L. Zawel, L. Fisher, J. M. Egly, and D. Reinberg. 1992. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358:641-645.
49. Meek, D. W., and W. Eckhart. 1988. Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells. Mol. Cell. Biol. 8:461-465.
50. Milne, D. M., D. G. Campbell, F. B. Caudwell, and D. W. Meek. 1994. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J. Biol. Chem. 269:9253-9260.
51. Milne, D. M., L. E. Campbell, D. G. Campbell, and D. W. Meek. 1995. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK-1. J. Biol. Chem. 270:5511-5518.
52. Milne, D. M., L. McKendrick, L. J. Jardine, E. Deacon, J. M. Lord, and D. W. Meek. 1996. Murine p53 is phosphorylated within the PAB-421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester O-tetradecanoylphorbol 13-acetate. Oncogene 13:205-211.
53. Milne, D. M., R. H. Palmer, D. G. Campbell, and D. W. Meek. 1992. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene 7:1361-1369.
54. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
55. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69:1237-1245.
56. Mummenbrauer, T., F. Janus, B. Muller, L. Wiesmuller, W. Deppert, and F. Grosse. 1996. p53 protein exhibits 3′-to-5′ exonuclease activity. Cell 85: 1089-1099.
57. Nacht, M., A. Strasser, Y. R. Chan, A. W. Harris, M. Schlissel, R. T. Bronson, and T. Jacks. 1996. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10:2055-2066.
58. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
59. Pavletich, N. P., K. A. Chambers, and C. O. Pabo. 1994. The DNA binding domain of p53 contains the four conserved regions and the major mutation hotspots. Genes Dev. 7:2556-2564.
60. Perry, M. E., J. Piette, J. Zawadzki, D. Harvey, and A. J. Levine. 1993. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90:11623-11627.
61. cdc2. EMBO J. 12:3123-3132.
62. Rathmell, W. K., W. K. Kaufmann, J. C. Hurt, L. L. Byrd, and G. Chu. 1997. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Cancer Res. 57:68-74.
63. Raycroft, L., H. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051.
64. Renzing, J., S. Hansen, and D. P. Lane. 1996. Oxidative stress is involved in the UV activation of p53. J. Cell Sci. 109:1105-1112.
65. Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J.-P. Tassan, L. Schaeffer, E. A. Nigg, J. H. J. Hoeijmakers, and J.-M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093-1101.
66. Samad, A., C. W. Anderson, and R. B. Carroll. 1986. Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. Proc. Natl. Acad. Sci. USA 83:897-901.
67. Schaeffer, L., V. Moncollin, R. Roy, A. Staub, M. Mezzina, A. Sarasin, G. Weeda, J. H. Hoeijmakers, and J. M. Egly. 1994. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 13:2388-2392.
68. Schaeffer, L., R. Roy, S. Humbert, V. Moncollin, W. Vermuden, J. H. S. Hoeymakers, P. Chambon, and J. M. Egly. 1993. DNA repair helicases: a component of BTF2 (TFIIH) basic transcription factor. Science 260:58-63.
69. Serizawa, H., T. P. Makela, J. W. Conaway, R. C. Conaway, R. A. Weinberg, and R. A. Young. 1995. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 374:280-287.
70. Shiekhattar, R., F. Mermelstein, R. P. Fisher, R. Drapkin, B. Dynlacht, H. C. Wessling, D. O. Morgan, and D. Reinberg. 1995. CDK-activating kinase complex is a component of human transcription factor TFIIH. Nature 374: 283-287.
71. cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12:3133-3142.
72. cdc2 activation: identification of an activating kinase. Mol. Biol. Cell 3:13-27.
73. Tassan, J. P., M. Jaquenoud, A. M. Fry, S. Frutiger, G. J. Hughes, and E. A. Nigg. 1995. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14:5608-5617.
74. Wang, X. W., H. Yeh, L. Schaeffer, R. Roy, V. Moncollin, J.-M. Egly, Z. Wang, E. C. Friedberg, M. K. Evans, B. G. Taffe, V. A. Bohr, G. Weeda, J. H. J. Hoeijmakers, K. Forrester, and C. C. Harris. 1995. p53 modulation of TFIIH associated nucleotide excision repair activity. Nat. Genet. 10:188-195.
75. Wang, X. W., W. Verneulen, J. D. Coursen, M. Gibson, S. E. Lupold, K. Forrester, G. Xu, L. Elmore, H. Yeh, J. H. Hoeijmakers, and C. C. Harris. 1996. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10:1219-1232.
76. Wang, Y., and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 276:88-91.
77. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1125-1132.
78. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, C. J. Ingles, and J. Greenblatt. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013-7024.
79. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
80. Xu, Y., and D. Baltimore. 1996. Dual roles of Atm in the cellular response to radiation and in cell growth control. Genes Dev. 10:2401-2410.
81. Yamaizumi, M., and T. Sugano. 1994. UV-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. Oncogene 9:2775-2784.